Surgical Research Progress of Sentinel Lymph Node Biopsy in Melanoma

References

• Masoud SJ, Perone JA, Farrow NE, Mosca PJ, Tyler DS, Beasley GM. Sentinel lymph node biopsy and completion lymph node dissection for melanoma [published correction appears in Curr Treat Options Oncol. 2019 Aug 29;20(10):76]. Curr Treat Options Oncol. 2018;19(11):1.
   Web of Science ®Google Scholar
• Han D, van Akkooi ACJ, Straker RJ, 3rd, et al. Current management of melanoma patients with nodal metastases. Clin Exp Metastasis. 2022;39(1):181–6. doi:10.1007/s10585-021-10099-7.
   PubMed Web of Science ®Google Scholar
• Thompson JF, Haydu LE, Uren RF, et al. Preoperative ultrasound assessment of regional lymph nodes in melanoma patients does not provide reliable nodal staging: results from a large multicenter trial. Ann Surg. 2021;273(4):814–820. doi:10.1097/SLA.0000000000003405.
   PubMed Web of Science ®Google Scholar
• Stahlie EHA, van der Hiel B, Bruining A, et al. The value of lymph node ultrasound and whole body 18F-FDG PET/CT in stage IIB/C melanoma patients prior to SLNB. Eur J Surg Oncol. 2021;47(5):1157–1162. doi:10.1016/j.ejso.2020.12.007.
   PubMed Web of Science ®Google Scholar
• Lee C, Collichio F, Ollila D, Moschos S. Historical review of melanoma treatment and outcomes. Clin Dermatol. 2013;31(2):141–147. doi:10.1016/j.clindermatol.2012.08.015.
   PubMed Web of Science ®Google Scholar
• Santamaria-Barria JA, Mammen JMV. Surgical management of melanoma: advances and updates. Curr Oncol Rep. 2022;24(11):1425–1432. doi:10.1007/s11912-022-01289-x.
   PubMed Web of Science ®Google Scholar
• Banting S, Milne D, Thorpe T, et al. Negative sentinel lymph node biopsy in patients with melanoma: the patient’s perspective. Ann Surg Oncol. 2019;26(7):2263–2267. doi:10.1245/s10434-019-07375-y.
   PubMed Web of Science ®Google Scholar
• Moody JA, Ali RF, Carbone AC, Singh S, Hardwicke JT. Complications of sentinel lymph node biopsy for melanoma - A systematic review of the literature. Eur J Surg Oncol. 2017;43(2):270–277. doi:10.1016/j.ejso.2016.06.407.
   PubMed Web of Science ®Google Scholar
• Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–399. doi:10.1001/archsurg.1992.01420040034005.
   PubMed Web of Science ®Google Scholar
• van Akkooi ACJ, Schadendorf D, Eggermont AMM. Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma. Eur J Cancer. 2023;182:163–169. doi:10.1016/j.ejca.2022.12.022.
   PubMed Web of Science ®Google Scholar
• Michielin O, van Akkooi ACJ, Ascierto PA, Dummer R, Keilholz U. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(12):1884–1901. doi:10.1093/annonc/mdz411.
   PubMed Web of Science ®Google Scholar
• Swetter SM, Thompson JA, Albertini MR, et al. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021. J Natl Compr Canc Netw. 2021;19(4):364–376. doi:10.6004/jnccn.2021.0018.
   PubMed Web of Science ®Google Scholar
• Sullivan RJ, Atkins MB, Kirkwood JM, et al. An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0. J Immunother Cancer. 2018;6(1):44.
   PubMedGoogle Scholar
• Long GV, Stroyakovskiy D, Gogas H, et al. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Lancet. 2015;386(9992):444–451. doi:10.1016/S0140-6736(15)60898-4.
   PubMed Web of Science ®Google Scholar
• De Ravin E, Suresh N, Romeo D, et al. Clinical practice guidelines on sentinel lymph node biopsy for melanoma: a systematic review and quality appraisal using the AGREE II instrument. Ann Surg Oncol. 2022;29(13):8364–8372. doi:10.1245/s10434-022-12525-w.
   PubMed Web of Science ®Google Scholar
• Sadurní MB, Meves A. Breslow thickness 2.0: why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies. Mod Pathol. 2022;35(11):1509–1514. doi:10.1038/s41379-022-01101-y.
   PubMed Web of Science ®Google Scholar
• Miller JR, Lo SN, Nosrati M, et al. Improving selection for sentinel lymph node biopsy among patients with melanoma. JAMA Netw Open. 2023;6(4):e236356. Published 2023 Apr 3. doi:10.1001/jamanetworkopen.2023.6356.
   PubMed Web of Science ®Google Scholar
• Amaral T, Sinnberg T, Chatziioannou E, et al. Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP). Eur J Cancer. 2023;182:155–162. doi:10.1016/j.ejca.2022.12.021.
   PubMed Web of Science ®Google Scholar
• Jarell A, Gastman BR, Dillon LD, et al. Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test. J Am Acad Dermatol. 2022;87(6):1312–1320. doi:10.1016/j.jaad.2022.06.1202.
   PubMed Web of Science ®Google Scholar
• Marchetti MA, Dusza SW, Bartlett EK. Utility of a model for predicting the risk of sentinel lymph node metastasis in patients with cutaneous melanoma. JAMA Dermatol. 2022;158(6):680–683. doi:10.1001/jamadermatol.2022.0970.
   PubMed Web of Science ®Google Scholar
• Cheraghlou S, Ugwu N, Girardi M. Sentinel lymph node biopsy positivity in patients with acral lentiginous and other subtypes of cutaneous melanoma. JAMA Dermatol. 2022;158(1):51–58. doi:10.1001/jamadermatol.2021.4812.
   PubMed Web of Science ®Google Scholar
• Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma [published correction appears in N Engl J Med. 2006 Nov 2;355(18):1944]. N Engl J Med. 2006;355(13):1307–1317. doi:10.1056/NEJMoa060992.
   PubMed Web of Science ®Google Scholar
• Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609. doi:10.1056/NEJMoa1310460.
   PubMed Web of Science ®Google Scholar
• Tejera-Vaquerizo A, Boada A, Ribero S, et al. Sentinel lymph node biopsy vs. observation in thin melanoma: a multicenter propensity score matching study. J Clin Med. 2021;10(24):5878. Published 2021 Dec 15.
   PubMed Web of Science ®Google Scholar
• Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–2222. doi:10.1056/NEJMoa1613210.
   PubMed Web of Science ®Google Scholar
• Morton DL. Overview and update of the phase III multicenter selective lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis. 2012;29(7):699–706. doi:10.1007/s10585-012-9503-3.
   PubMed Web of Science ®Google Scholar
• Leiter U, Stadler R, Mauch C, et al. Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol. 2019;37(32):3000–3008. doi:10.1200/JCO.18.02306.
   PubMed Web of Science ®Google Scholar
• Sun W, Xu Y, Yang J, et al. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study. Cancer Commun (Lond). 2020;40(11):586–597. doi:10.1002/cac2.12101.
   PubMed Web of Science ®Google Scholar
• Parvez E, Khosrow-Khavar F, Dumitra T, et al. Multicenter adoption and outcomes of nodal observation for patients with melanoma and sentinel lymph node metastases. Ann Surg Oncol. 2023;30(2):1195–1205. doi:10.1245/s10434-022-12695-7.
   PubMed Web of Science ®Google Scholar
• Castle JT, Adatorwovor R, Levy BE, et al. Completion Lymph Node Dissection for Melanoma Before and After the Multicenter Selective Lymphadenectomy Trial-II in the United States. Ann Surg Oncol. 2023;30(2):1184–1193. doi:10.1245/s10434-022-12745-0.
   PubMed Web of Science ®Google Scholar
• Blankenstein SA, Bonenkamp JJ, Aarts MJB, et al. Is a history of optimal staging by sentinel lymph node biopsy in the era prior to adjuvant therapy associated with improved outcome once melanoma patients have progressed to advanced disease? Ann Surg Oncol. 2023;30(1):573–586. doi:10.1245/s10434-022-12600-2.
   PubMed Web of Science ®Google Scholar
• Farlow JL, McLean SA, Peddireddy N, et al. Impact of completion lymphadenectomy on quality of life for head and neck cutaneous melanoma. Otolaryngol Head Neck Surg. 2022;166(2):313–320. doi:10.1177/01945998211007442.
   PubMed Web of Science ®Google Scholar
• Lin D, Franc BL, Kashani-Sabet M, Singer MI. Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck. 2006;28(3):249–255. doi:10.1002/hed.20328.
   PubMed Web of Science ®Google Scholar
• Pasha T, Arain Z, Buscombe J, et al. Association of complex lymphatic drainage in head and neck cutaneous melanoma with sentinel lymph node biopsy outcomes: a cohort study and literature review. JAMA Otolaryngol Head Neck Surg. 2023;149(5):416–423. doi:10.1001/jamaoto.2023.0076.
   PubMed Web of Science ®Google Scholar
• Bello DM, Faries MB. The landmark series: MSLT-1, MSLT-2 and DeCOG (management of lymph nodes). Ann Surg Oncol. 2020;27(1):15–21. doi:10.1245/s10434-019-07830-w.
   PubMed Web of Science ®Google Scholar
• Chi Z, Li S, Sheng X, et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer. 2011;11:85. doi:10.1186/1471-2407-11-85.
   PubMed Web of Science ®Google Scholar
• Wu PC, Chen YC, Chen HM, Chen LW. Prognostic factors and population-based analysis of melanoma with sentinel lymph node biopsy. Sci Rep. 2021;11(1):20524. doi:10.1038/s41598-021-99950-1.
   PubMed Web of Science ®Google Scholar
• Jones O, Murphy SH, Biosse-Duplan G, Patel AJK, Roshan A, Durrani AJ. Lymph node dissections in cutaneous malignancy: Where are we now? A review of 10 years’ experience at a tertiary centre. J Plast Reconstr Aesthet Surg. 2021;74(11):2993–2998. doi:10.1016/j.bjps.2021.03.115.
   PubMed Web of Science ®Google Scholar
• Broman KK, Hughes T, Dossett L, et al. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Cancer. 2021;127(13):2251–2261. doi:10.1002/cncr.33483.
   PubMed Web of Science ®Google Scholar
• Broman KK, Hughes TM, Bredbeck BC, et al. International center-level variation in utilization of completion lymph node dissection and adjuvant systemic therapy for sentinel lymph node positive melanoma at major referral centers. Ann Surg. 2023;277(5):e1106–e1115. 27: doi:10.1097/SLA.0000000000005370.
   PubMed Web of Science ®Google Scholar
• Keung EZ, Gershenwald JE. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther. 2018;18(8):775–784. doi:10.1080/14737140.2018.1489246.
   PubMed Web of Science ®Google Scholar
• Niebling MG, Pleijhuis RG, Bastiaannet E, Brouwers AH, van Dam GM, Hoekstra HJ. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol. 2016;42(4):466–473. doi:10.1016/j.ejso.2015.12.007.
   PubMed Web of Science ®Google Scholar
• Kim TH, Kim HJ, Seo JW, Song KH. Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities. Br J Dermatol. 2020;182(2):427–433. doi:10.1111/bjd.18121.
   PubMed Web of Science ®Google Scholar
• Leong SP. Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®). Clin Exp Metastasis. 2022;39(1):39–50. doi:10.1007/s10585-021-10137-4.
   PubMed Web of Science ®Google Scholar
• Moncrieff MD, O’Leary FM, Beadsmoore CJ, et al. Effect of delay between nuclear medicine scanning and sentinel node biopsy on outcome in patients with cutaneous melanoma. Br J Surg. 2020;107(6):669–676. doi:10.1002/bjs.11460.
   PubMed Web of Science ®Google Scholar
• O’Leary FM, Beadsmoore CJ, Pawaroo D, Skrypniuk J, Heaton MJ, Moncrieff MD. Survival outcomes and interval between lymphoscintigraphy and SLNB in cutaneous melanoma-findings of a large prospective cohort study. Eur J Surg Oncol. 2018;44(11):1768–1772. doi:10.1016/j.ejso.2018.06.011.
   PubMed Web of Science ®Google Scholar
• Fujiwara M, Mizukami T, Suzuki A, Fukamizu H. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J Plast Reconstr Aesthet Surg. 2009;62(10):e373–e378. doi:10.1016/j.bjps.2007.12.074.
   PubMed Web of Science ®Google Scholar
• Burnier P, Niddam J, Bosc R, Hersant B, Meningaud JP. Indocyanine green applications in plastic surgery: A review of the literature. J Plast Reconstr Aesthet Surg. 2017;70(6):814–827. doi:10.1016/j.bjps.2017.01.020.
   PubMed Web of Science ®Google Scholar
• Lafreniere AS, Shine JJ, Nicholas CR, Temple-Oberle CF. The use of indocyanine green and near-infrared fluorescence imaging to assist sentinel lymph node biopsy in cutaneous melanoma: a systematic review. Eur J Surg Oncol. 2021;47(5):935–941. doi:10.1016/j.ejso.2020.10.027.
   PubMed Web of Science ®Google Scholar
• Valhondo-Rama R, Sánchez Izquierdo N, Tapias Mesa A, Perissinotti A, Vidal-Sicart S. Comparison of 99mTc-tilmanocept and hybrid indocyanine green-99mTc-albumin nanocolloid drainage in a patient with melanoma in the scalp. Clin Nucl Med. 2020;45(12):977–979. doi:10.1097/RLU.0000000000003309.
   PubMed Web of Science ®Google Scholar
• Di Paola V, Mazzotta G, Conti M, et al. Image-guided localization techniques for metastatic axillary lymph nodes in breast cancer; what radiologists should know. Cancers (Basel). 2023;15(7):2130. doi:10.3390/cancers15072130.
   PubMed Web of Science ®Google Scholar
• Seth R, Messersmith H, Funchain P. Systemic therapy for melanoma guideline expert panel. systemic therapy for melanoma: ASCO guideline rapid recommendation update [published correction appears in J Clin Oncol. 2022 Sep 10;40(26):3098]. J Clin Oncol. 2022;40(21):2375–2377. doi:10.1200/JCO.22.00944.
   PubMedGoogle Scholar
• Allard-Coutu A, Dobson V, Schmitz E, Shah H, Nessim C. The evolution of the sentinel node biopsy in melanoma. Life (Basel). 2023;13(2):489.
   PubMed Web of Science ®Google Scholar